Predictive and Pharmacodynamic Biomarkers of Response to the Phosphatidylinositol 3-Kinase Inhibitor Taselisib in Breast Cancer Preclinical Models

Heather M. Moore, Timothy R. Wilson, Carol O’Brien et al.|Molecular Cancer Therapeutics|2019

Cited by 10